Status:
COMPLETED
Non-Persistence/Non-Adherence (NP/NA) in Wet Age-related Macular Degeneration (wAMD) Patients in Germany
Lead Sponsor:
Bayer
Conditions:
Wet Macular Degeneration
Eligibility:
All Genders
18+ years
Brief Summary
In the research study an observation of patients with wet age-related macular degeneration (wet AMD) will be performed. The term observational study indicates that the current course of therapy and t...
Eligibility Criteria
Inclusion
- Patient has wet age-related macular degeneration (wAMD)
- Patient has already received at least one Anti-VEGF injection
- From a clinical standpoint, if there is an ophthalmological need for treatment it is probable that the patient gets additional anti-VEGF injections in the next year.
- The patient is able and willing to take part in the study (answering a short questionnaire in the study centre, 4 independent phone interviews during study period).
Exclusion
- At time of inclusion visit, the study centre is only exceptionally responsible for the treatment of the patient.
- The patient is taking part in another study.
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT01448538
Start Date
August 1 2011
End Date
February 1 2014
Last Update
September 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Germany